encepp

Post-marketing Surveillance Study of the Effectiveness and Safety of new Oral Antivirals for outpatients with mild-moderate COVID-19. (ESOA-19)

18/07/2022
05/06/2025
EU PAS number:
EUPAS48186
Study
Planned
Documents
Study protocol
Study results
Study results
English (1.16 MB - PDF) View document
Study report
Other information
Publications
ENCePP Seal
This study has been awarded the ENCePP seal
Conflicts of interest of investigators
English (160.73 KB - PDF) View document
Composition of steering group and observers
English (400.67 KB - PDF) View document